nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—ALB—liver cancer	0.21	1	CbGaD
Flurbiprofen—UGT2B7—Epirubicin—liver cancer	0.139	0.277	CbGbCtD
Flurbiprofen—UGT1A9—Sorafenib—liver cancer	0.129	0.256	CbGbCtD
Flurbiprofen—ABCC4—Sorafenib—liver cancer	0.108	0.214	CbGbCtD
Flurbiprofen—UGT1A1—Sorafenib—liver cancer	0.106	0.21	CbGbCtD
Flurbiprofen—CYP2C9—Sorafenib—liver cancer	0.0216	0.0428	CbGbCtD
Flurbiprofen—L-Phenylalanine—TAT—liver cancer	0.00173	0.48	CrCbGaD
Flurbiprofen—Sepsis—Epirubicin—liver cancer	0.000305	0.00235	CcSEcCtD
Flurbiprofen—Dyspnoea—Sorafenib—liver cancer	0.000303	0.00233	CcSEcCtD
Flurbiprofen—Lymphadenopathy—Epirubicin—liver cancer	0.000299	0.00231	CcSEcCtD
Flurbiprofen—Dyspepsia—Sorafenib—liver cancer	0.000299	0.0023	CcSEcCtD
Flurbiprofen—Oesophagitis—Doxorubicin—liver cancer	0.000297	0.00229	CcSEcCtD
Flurbiprofen—Coma—Doxorubicin—liver cancer	0.000297	0.00229	CcSEcCtD
Flurbiprofen—Phlebitis—Epirubicin—liver cancer	0.000296	0.00228	CcSEcCtD
Flurbiprofen—Decreased appetite—Sorafenib—liver cancer	0.000295	0.00228	CcSEcCtD
Flurbiprofen—Ecchymosis—Doxorubicin—liver cancer	0.000294	0.00227	CcSEcCtD
Flurbiprofen—Bladder pain—Doxorubicin—liver cancer	0.000294	0.00227	CcSEcCtD
Flurbiprofen—Photosensitivity—Epirubicin—liver cancer	0.000291	0.00224	CcSEcCtD
Flurbiprofen—Constipation—Sorafenib—liver cancer	0.00029	0.00224	CcSEcCtD
Flurbiprofen—Pain—Sorafenib—liver cancer	0.00029	0.00224	CcSEcCtD
Flurbiprofen—Ibuprofen—PPARG—liver cancer	0.000289	0.0802	CrCbGaD
Flurbiprofen—Vascular purpura—Epirubicin—liver cancer	0.000285	0.0022	CcSEcCtD
Flurbiprofen—Hypertonia—Doxorubicin—liver cancer	0.000285	0.0022	CcSEcCtD
Flurbiprofen—Hepatic failure—Epirubicin—liver cancer	0.000284	0.00219	CcSEcCtD
Flurbiprofen—Eczema—Epirubicin—liver cancer	0.000284	0.00219	CcSEcCtD
Flurbiprofen—Sepsis—Doxorubicin—liver cancer	0.000282	0.00218	CcSEcCtD
Flurbiprofen—Cardiac failure congestive—Epirubicin—liver cancer	0.000281	0.00217	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Sorafenib—liver cancer	0.000278	0.00214	CcSEcCtD
Flurbiprofen—Lymphadenopathy—Doxorubicin—liver cancer	0.000277	0.00213	CcSEcCtD
Flurbiprofen—Phlebitis—Doxorubicin—liver cancer	0.000274	0.00211	CcSEcCtD
Flurbiprofen—Increased appetite—Epirubicin—liver cancer	0.000272	0.00209	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Epirubicin—liver cancer	0.00027	0.00209	CcSEcCtD
Flurbiprofen—Urticaria—Sorafenib—liver cancer	0.00027	0.00208	CcSEcCtD
Flurbiprofen—Photosensitivity—Doxorubicin—liver cancer	0.000269	0.00207	CcSEcCtD
Flurbiprofen—Abdominal pain—Sorafenib—liver cancer	0.000268	0.00207	CcSEcCtD
Flurbiprofen—Body temperature increased—Sorafenib—liver cancer	0.000268	0.00207	CcSEcCtD
Flurbiprofen—Renal impairment—Epirubicin—liver cancer	0.000268	0.00207	CcSEcCtD
Flurbiprofen—Purpura—Epirubicin—liver cancer	0.000265	0.00204	CcSEcCtD
Flurbiprofen—Vascular purpura—Doxorubicin—liver cancer	0.000264	0.00204	CcSEcCtD
Flurbiprofen—Hepatic failure—Doxorubicin—liver cancer	0.000263	0.00203	CcSEcCtD
Flurbiprofen—Eczema—Doxorubicin—liver cancer	0.000263	0.00203	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Epirubicin—liver cancer	0.00026	0.00201	CcSEcCtD
Flurbiprofen—Cardiac failure congestive—Doxorubicin—liver cancer	0.00026	0.00201	CcSEcCtD
Flurbiprofen—Warfarin—CYP1A1—liver cancer	0.000257	0.0713	CrCbGaD
Flurbiprofen—Osteoarthritis—Epirubicin—liver cancer	0.000255	0.00197	CcSEcCtD
Flurbiprofen—Diplopia—Epirubicin—liver cancer	0.000255	0.00197	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000255	0.00197	CcSEcCtD
Flurbiprofen—Increased appetite—Doxorubicin—liver cancer	0.000251	0.00194	CcSEcCtD
Flurbiprofen—Affect lability—Epirubicin—liver cancer	0.000251	0.00194	CcSEcCtD
Flurbiprofen—Migraine—Epirubicin—liver cancer	0.000251	0.00194	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00025	0.00193	CcSEcCtD
Flurbiprofen—Diflunisal—ALB—liver cancer	0.00025	0.0695	CrCbGaD
Flurbiprofen—Hypersensitivity—Sorafenib—liver cancer	0.00025	0.00193	CcSEcCtD
Flurbiprofen—Renal impairment—Doxorubicin—liver cancer	0.000248	0.00191	CcSEcCtD
Flurbiprofen—Purpura—Doxorubicin—liver cancer	0.000245	0.00189	CcSEcCtD
Flurbiprofen—Asthenia—Sorafenib—liver cancer	0.000243	0.00188	CcSEcCtD
Flurbiprofen—Mood swings—Epirubicin—liver cancer	0.000242	0.00186	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Doxorubicin—liver cancer	0.000241	0.00186	CcSEcCtD
Flurbiprofen—Pruritus—Sorafenib—liver cancer	0.00024	0.00185	CcSEcCtD
Flurbiprofen—Ataxia—Epirubicin—liver cancer	0.00024	0.00185	CcSEcCtD
Flurbiprofen—Diplopia—Doxorubicin—liver cancer	0.000236	0.00182	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000236	0.00182	CcSEcCtD
Flurbiprofen—Osteoarthritis—Doxorubicin—liver cancer	0.000236	0.00182	CcSEcCtD
Flurbiprofen—Dry skin—Epirubicin—liver cancer	0.000234	0.0018	CcSEcCtD
Flurbiprofen—Affect lability—Doxorubicin—liver cancer	0.000232	0.00179	CcSEcCtD
Flurbiprofen—Migraine—Doxorubicin—liver cancer	0.000232	0.00179	CcSEcCtD
Flurbiprofen—Diarrhoea—Sorafenib—liver cancer	0.000232	0.00179	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00023	0.00177	CcSEcCtD
Flurbiprofen—Gastritis—Epirubicin—liver cancer	0.000226	0.00174	CcSEcCtD
Flurbiprofen—Muscular weakness—Epirubicin—liver cancer	0.000225	0.00174	CcSEcCtD
Flurbiprofen—Dizziness—Sorafenib—liver cancer	0.000224	0.00173	CcSEcCtD
Flurbiprofen—Mood swings—Doxorubicin—liver cancer	0.000224	0.00173	CcSEcCtD
Flurbiprofen—Abdominal distension—Epirubicin—liver cancer	0.000222	0.00171	CcSEcCtD
Flurbiprofen—Ataxia—Doxorubicin—liver cancer	0.000222	0.00171	CcSEcCtD
Flurbiprofen—Asthma—Epirubicin—liver cancer	0.000221	0.0017	CcSEcCtD
Flurbiprofen—Influenza—Epirubicin—liver cancer	0.000221	0.0017	CcSEcCtD
Flurbiprofen—Eosinophilia—Epirubicin—liver cancer	0.000218	0.00168	CcSEcCtD
Flurbiprofen—Dry skin—Doxorubicin—liver cancer	0.000216	0.00167	CcSEcCtD
Flurbiprofen—Pancreatitis—Epirubicin—liver cancer	0.000216	0.00167	CcSEcCtD
Flurbiprofen—Vomiting—Sorafenib—liver cancer	0.000216	0.00166	CcSEcCtD
Flurbiprofen—Angina pectoris—Epirubicin—liver cancer	0.000215	0.00166	CcSEcCtD
Flurbiprofen—Rash—Sorafenib—liver cancer	0.000214	0.00165	CcSEcCtD
Flurbiprofen—Dermatitis—Sorafenib—liver cancer	0.000214	0.00165	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000213	0.00164	CcSEcCtD
Flurbiprofen—Headache—Sorafenib—liver cancer	0.000213	0.00164	CcSEcCtD
Flurbiprofen—Bronchitis—Epirubicin—liver cancer	0.000212	0.00164	CcSEcCtD
Flurbiprofen—Pancytopenia—Epirubicin—liver cancer	0.000209	0.00162	CcSEcCtD
Flurbiprofen—Gastritis—Doxorubicin—liver cancer	0.000209	0.00161	CcSEcCtD
Flurbiprofen—Muscular weakness—Doxorubicin—liver cancer	0.000208	0.00161	CcSEcCtD
Flurbiprofen—Dysuria—Epirubicin—liver cancer	0.000206	0.00159	CcSEcCtD
Flurbiprofen—Neutropenia—Epirubicin—liver cancer	0.000206	0.00159	CcSEcCtD
Flurbiprofen—Abdominal distension—Doxorubicin—liver cancer	0.000205	0.00158	CcSEcCtD
Flurbiprofen—Asthma—Doxorubicin—liver cancer	0.000204	0.00157	CcSEcCtD
Flurbiprofen—Influenza—Doxorubicin—liver cancer	0.000204	0.00157	CcSEcCtD
Flurbiprofen—Eosinophilia—Doxorubicin—liver cancer	0.000202	0.00156	CcSEcCtD
Flurbiprofen—Nausea—Sorafenib—liver cancer	0.000202	0.00155	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Epirubicin—liver cancer	0.000201	0.00155	CcSEcCtD
Flurbiprofen—Pancreatitis—Doxorubicin—liver cancer	0.0002	0.00154	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Epirubicin—liver cancer	0.000199	0.00153	CcSEcCtD
Flurbiprofen—Angina pectoris—Doxorubicin—liver cancer	0.000199	0.00153	CcSEcCtD
Flurbiprofen—Pneumonia—Epirubicin—liver cancer	0.000198	0.00153	CcSEcCtD
Flurbiprofen—Drowsiness—Epirubicin—liver cancer	0.000197	0.00152	CcSEcCtD
Flurbiprofen—Bronchitis—Doxorubicin—liver cancer	0.000196	0.00151	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000195	0.0015	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—liver cancer	0.000194	0.00149	CcSEcCtD
Flurbiprofen—Renal failure—Epirubicin—liver cancer	0.000193	0.00149	CcSEcCtD
Flurbiprofen—Jaundice—Epirubicin—liver cancer	0.000192	0.00148	CcSEcCtD
Flurbiprofen—Stomatitis—Epirubicin—liver cancer	0.000192	0.00148	CcSEcCtD
Flurbiprofen—Urinary tract infection—Epirubicin—liver cancer	0.000191	0.00147	CcSEcCtD
Flurbiprofen—Conjunctivitis—Epirubicin—liver cancer	0.000191	0.00147	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—liver cancer	0.000191	0.00147	CcSEcCtD
Flurbiprofen—Dysuria—Doxorubicin—liver cancer	0.000191	0.00147	CcSEcCtD
Flurbiprofen—Sweating—Epirubicin—liver cancer	0.000189	0.00145	CcSEcCtD
Flurbiprofen—Haematuria—Epirubicin—liver cancer	0.000187	0.00145	CcSEcCtD
Flurbiprofen—Fenoprofen—ALB—liver cancer	0.000187	0.0519	CrCbGaD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—liver cancer	0.000186	0.00144	CcSEcCtD
Flurbiprofen—Epistaxis—Epirubicin—liver cancer	0.000185	0.00143	CcSEcCtD
Flurbiprofen—Sinusitis—Epirubicin—liver cancer	0.000184	0.00142	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—liver cancer	0.000184	0.00142	CcSEcCtD
Flurbiprofen—Agranulocytosis—Epirubicin—liver cancer	0.000184	0.00142	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—liver cancer	0.000183	0.00141	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—liver cancer	0.000182	0.0014	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00018	0.00139	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—liver cancer	0.000179	0.00138	CcSEcCtD
Flurbiprofen—Haemoglobin—Epirubicin—liver cancer	0.000177	0.00137	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—liver cancer	0.000177	0.00137	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—liver cancer	0.000177	0.00137	CcSEcCtD
Flurbiprofen—Rhinitis—Epirubicin—liver cancer	0.000177	0.00136	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—liver cancer	0.000177	0.00136	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—liver cancer	0.000177	0.00136	CcSEcCtD
Flurbiprofen—Hepatitis—Epirubicin—liver cancer	0.000177	0.00136	CcSEcCtD
Flurbiprofen—Haemorrhage—Epirubicin—liver cancer	0.000177	0.00136	CcSEcCtD
Flurbiprofen—Pharyngitis—Epirubicin—liver cancer	0.000175	0.00135	CcSEcCtD
Flurbiprofen—Sweating—Doxorubicin—liver cancer	0.000174	0.00135	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—liver cancer	0.000173	0.00134	CcSEcCtD
Flurbiprofen—Epistaxis—Doxorubicin—liver cancer	0.000172	0.00132	CcSEcCtD
Flurbiprofen—Nitrazepam—CYP2E1—liver cancer	0.000171	0.0476	CrCbGaD
Flurbiprofen—Sinusitis—Doxorubicin—liver cancer	0.000171	0.00132	CcSEcCtD
Flurbiprofen—Naproxen—ALB—liver cancer	0.00017	0.0473	CrCbGaD
Flurbiprofen—Visual impairment—Epirubicin—liver cancer	0.00017	0.00131	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—liver cancer	0.00017	0.00131	CcSEcCtD
Flurbiprofen—Erythema multiforme—Epirubicin—liver cancer	0.000167	0.00129	CcSEcCtD
Flurbiprofen—Tinnitus—Epirubicin—liver cancer	0.000165	0.00127	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—liver cancer	0.000164	0.00127	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—liver cancer	0.000164	0.00126	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—liver cancer	0.000163	0.00126	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—liver cancer	0.000163	0.00126	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—liver cancer	0.000162	0.00125	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—liver cancer	0.00016	0.00124	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—liver cancer	0.000158	0.00122	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—liver cancer	0.000158	0.00122	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—liver cancer	0.000157	0.00121	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—liver cancer	0.000156	0.0012	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—liver cancer	0.000154	0.00119	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—liver cancer	0.000152	0.00117	CcSEcCtD
Flurbiprofen—Flatulence—Epirubicin—liver cancer	0.000151	0.00117	CcSEcCtD
Flurbiprofen—Tension—Epirubicin—liver cancer	0.000151	0.00116	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—liver cancer	0.000149	0.00115	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—liver cancer	0.000148	0.00114	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—liver cancer	0.000147	0.00113	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—liver cancer	0.000146	0.00113	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—liver cancer	0.000144	0.00111	CcSEcCtD
Flurbiprofen—Warfarin—ALB—liver cancer	0.000143	0.0397	CrCbGaD
Flurbiprofen—Ill-defined disorder—Epirubicin—liver cancer	0.000143	0.0011	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—liver cancer	0.000142	0.0011	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—liver cancer	0.00014	0.00108	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—liver cancer	0.00014	0.00108	CcSEcCtD
Flurbiprofen—Malaise—Epirubicin—liver cancer	0.000139	0.00107	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—liver cancer	0.000138	0.00107	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—liver cancer	0.000138	0.00106	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—liver cancer	0.000138	0.00106	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—liver cancer	0.000138	0.00106	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—liver cancer	0.000136	0.00105	CcSEcCtD
Flurbiprofen—Loss of consciousness—Epirubicin—liver cancer	0.000135	0.00104	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—liver cancer	0.000134	0.00103	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—liver cancer	0.000133	0.00103	CcSEcCtD
Flurbiprofen—Hypertension—Epirubicin—liver cancer	0.000133	0.00102	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—liver cancer	0.000132	0.00102	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—liver cancer	0.000131	0.00101	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—liver cancer	0.000131	0.00101	CcSEcCtD
Flurbiprofen—Anxiety—Epirubicin—liver cancer	0.00013	0.00101	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—liver cancer	0.000129	0.000997	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—liver cancer	0.000128	0.000989	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—liver cancer	0.000128	0.000987	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—liver cancer	0.000128	0.000985	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—liver cancer	0.000128	0.000983	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—liver cancer	0.000127	0.000982	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—liver cancer	0.000126	0.000975	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—liver cancer	0.000126	0.000969	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—liver cancer	0.000125	0.000967	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—liver cancer	0.000125	0.000967	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—liver cancer	0.000125	0.000964	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—liver cancer	0.000125	0.000961	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—liver cancer	0.000124	0.000957	CcSEcCtD
Flurbiprofen—Shock—Epirubicin—liver cancer	0.000123	0.000952	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—liver cancer	0.000123	0.00095	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—liver cancer	0.000123	0.000947	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—liver cancer	0.000123	0.000947	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—liver cancer	0.000122	0.000944	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—liver cancer	0.000121	0.000935	CcSEcCtD
Flurbiprofen—Diazepam—CYP2E1—liver cancer	0.000121	0.0336	CrCbGaD
Flurbiprofen—Myalgia—Doxorubicin—liver cancer	0.000121	0.000934	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—liver cancer	0.000121	0.00093	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—liver cancer	0.00012	0.000922	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—liver cancer	0.00012	0.000922	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—liver cancer	0.000118	0.000913	CcSEcCtD
Flurbiprofen—Hypotension—Epirubicin—liver cancer	0.000117	0.000904	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—liver cancer	0.000117	0.000902	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—liver cancer	0.000116	0.000895	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—liver cancer	0.000116	0.000895	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—liver cancer	0.000115	0.000889	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000114	0.000881	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—liver cancer	0.000114	0.000881	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—liver cancer	0.000114	0.000876	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—liver cancer	0.000113	0.000875	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—liver cancer	0.000113	0.000873	CcSEcCtD
Flurbiprofen—Paraesthesia—Epirubicin—liver cancer	0.000113	0.000869	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—liver cancer	0.000112	0.000865	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—liver cancer	0.000112	0.000862	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—liver cancer	0.000111	0.00086	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—liver cancer	0.000111	0.000853	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—liver cancer	0.00011	0.000851	CcSEcCtD
Flurbiprofen—Ketoprofen—ALB—liver cancer	0.00011	0.0306	CrCbGaD
Flurbiprofen—Decreased appetite—Epirubicin—liver cancer	0.000109	0.000841	CcSEcCtD
Flurbiprofen—Ibuprofen—ALB—liver cancer	0.000109	0.0302	CrCbGaD
Flurbiprofen—Hypotension—Doxorubicin—liver cancer	0.000108	0.000836	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—liver cancer	0.000107	0.000827	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—liver cancer	0.000107	0.000827	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000106	0.000815	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—liver cancer	0.000105	0.000809	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—liver cancer	0.000104	0.000804	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—liver cancer	0.000103	0.000798	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—liver cancer	0.000103	0.000797	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—liver cancer	0.000103	0.000796	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Epirubicin—liver cancer	0.000103	0.000791	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—liver cancer	0.000102	0.000788	CcSEcCtD
Flurbiprofen—Decreased appetite—Doxorubicin—liver cancer	0.000101	0.000778	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—liver cancer	9.96e-05	0.000768	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—liver cancer	9.92e-05	0.000765	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—liver cancer	9.92e-05	0.000765	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—liver cancer	9.91e-05	0.000765	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—liver cancer	9.91e-05	0.000765	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—liver cancer	9.56e-05	0.000738	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—liver cancer	9.49e-05	0.000732	CcSEcCtD
Flurbiprofen—Hypersensitivity—Epirubicin—liver cancer	9.24e-05	0.000713	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—liver cancer	9.22e-05	0.000711	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—liver cancer	9.17e-05	0.000708	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—liver cancer	9.17e-05	0.000708	CcSEcCtD
Flurbiprofen—Asthenia—Epirubicin—liver cancer	9e-05	0.000694	CcSEcCtD
Flurbiprofen—Pruritus—Epirubicin—liver cancer	8.87e-05	0.000684	CcSEcCtD
Flurbiprofen—Diarrhoea—Epirubicin—liver cancer	8.58e-05	0.000662	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—liver cancer	8.55e-05	0.000659	CcSEcCtD
Flurbiprofen—Asthenia—Doxorubicin—liver cancer	8.33e-05	0.000642	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—liver cancer	8.29e-05	0.00064	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—liver cancer	8.21e-05	0.000633	CcSEcCtD
Flurbiprofen—Vomiting—Epirubicin—liver cancer	7.97e-05	0.000615	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—liver cancer	7.94e-05	0.000612	CcSEcCtD
Flurbiprofen—Rash—Epirubicin—liver cancer	7.91e-05	0.00061	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—liver cancer	7.9e-05	0.000609	CcSEcCtD
Flurbiprofen—Headache—Epirubicin—liver cancer	7.86e-05	0.000606	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—liver cancer	7.67e-05	0.000592	CcSEcCtD
Flurbiprofen—Nausea—Epirubicin—liver cancer	7.45e-05	0.000575	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—liver cancer	7.38e-05	0.000569	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—liver cancer	7.32e-05	0.000564	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—liver cancer	7.31e-05	0.000564	CcSEcCtD
Flurbiprofen—Headache—Doxorubicin—liver cancer	7.27e-05	0.000561	CcSEcCtD
Flurbiprofen—Nausea—Doxorubicin—liver cancer	6.89e-05	0.000532	CcSEcCtD
Flurbiprofen—Diazepam—ALB—liver cancer	6.65e-05	0.0185	CrCbGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.61e-05	0.000106	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NAT2—liver cancer	1.61e-05	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	1.61e-05	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HGF—liver cancer	1.59e-05	0.000104	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—MTHFR—liver cancer	1.57e-05	0.000103	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.57e-05	0.000103	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CSF2—liver cancer	1.57e-05	0.000103	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NR1H4—liver cancer	1.56e-05	0.000102	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VEGFA—liver cancer	1.56e-05	0.000102	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.55e-05	0.000101	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALDOB—liver cancer	1.54e-05	0.000101	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARA—liver cancer	1.54e-05	0.000101	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	1.54e-05	0.000101	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTA3—liver cancer	1.53e-05	0.0001	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYCS—liver cancer	1.52e-05	9.94e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYCS—liver cancer	1.52e-05	9.94e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GSTM1—liver cancer	1.51e-05	9.9e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GOT1—liver cancer	1.49e-05	9.75e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GGT1—liver cancer	1.49e-05	9.75e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GGT1—liver cancer	1.49e-05	9.75e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GOT1—liver cancer	1.49e-05	9.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.48e-05	9.71e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	1.47e-05	9.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CRABP1—liver cancer	1.47e-05	9.64e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.47e-05	9.62e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ADAM17—liver cancer	1.46e-05	9.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.45e-05	9.49e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PSMA4—liver cancer	1.45e-05	9.46e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PSMD10—liver cancer	1.45e-05	9.46e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.43e-05	9.4e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CYP1A1—liver cancer	1.43e-05	9.39e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.43e-05	9.38e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TGFB1—liver cancer	1.43e-05	9.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GOT2—liver cancer	1.41e-05	9.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTA4—liver cancer	1.4e-05	9.18e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PSMA4—liver cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PSMD10—liver cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	1.37e-05	8.95e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTA2—liver cancer	1.37e-05	8.94e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTP1—liver cancer	1.34e-05	8.76e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTP1—liver cancer	1.34e-05	8.76e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MTHFR—liver cancer	1.34e-05	8.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—GOT2—liver cancer	1.33e-05	8.73e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.33e-05	8.68e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—liver cancer	1.32e-05	8.67e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GLUL—liver cancer	1.32e-05	8.66e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CPT1B—liver cancer	1.32e-05	8.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP2E1—liver cancer	1.32e-05	8.66e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CG—liver cancer	1.32e-05	8.65e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—HMOX1—liver cancer	1.32e-05	8.64e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—HMOX1—liver cancer	1.32e-05	8.64e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTA1—liver cancer	1.32e-05	8.63e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARA—liver cancer	1.31e-05	8.59e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NAT2—liver cancer	1.3e-05	8.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HPGDS—liver cancer	1.29e-05	8.43e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.28e-05	8.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.28e-05	8.38e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NR1H4—liver cancer	1.28e-05	8.35e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—liver cancer	1.27e-05	8.35e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—MAPK14—liver cancer	1.27e-05	8.32e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	1.25e-05	8.22e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA3—liver cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.25e-05	8.2e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALDOB—liver cancer	1.25e-05	8.18e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYCS—liver cancer	1.24e-05	8.1e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—F2—liver cancer	1.23e-05	8.06e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTM1—liver cancer	1.23e-05	8.05e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTM1—liver cancer	1.23e-05	8.05e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PIK3CA—liver cancer	1.22e-05	7.97e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GGT1—liver cancer	1.21e-05	7.95e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GOT1—liver cancer	1.21e-05	7.95e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.21e-05	7.93e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CRABP1—liver cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CG—liver cancer	1.18e-05	7.72e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—liver cancer	1.18e-05	7.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.17e-05	7.63e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP1A1—liver cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP1A1—liver cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CD—liver cancer	1.16e-05	7.6e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—liver cancer	1.15e-05	7.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.15e-05	7.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—GOT1—liver cancer	1.15e-05	7.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PSMD10—liver cancer	1.15e-05	7.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PSMA4—liver cancer	1.15e-05	7.51e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA4—liver cancer	1.15e-05	7.51e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ALB—liver cancer	1.15e-05	7.51e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—liver cancer	1.13e-05	7.37e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CG—liver cancer	1.12e-05	7.35e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.12e-05	7.34e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA2—liver cancer	1.12e-05	7.32e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GOT2—liver cancer	1.12e-05	7.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTP1—liver cancer	1.09e-05	7.14e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MTHFR—liver cancer	1.09e-05	7.11e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MTHFR—liver cancer	1.09e-05	7.11e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—liver cancer	1.08e-05	7.1e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA1—liver cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—HMOX1—liver cancer	1.08e-05	7.04e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.07e-05	7.03e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.07e-05	6.99e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NAT2—liver cancer	1.07e-05	6.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARA—liver cancer	1.07e-05	6.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARA—liver cancer	1.07e-05	6.98e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PRKCE—liver cancer	1.06e-05	6.95e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2E1—liver cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HPGDS—liver cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CD—liver cancer	1.04e-05	6.78e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.04e-05	6.78e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.03e-05	6.71e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SERPINE1—liver cancer	1.02e-05	6.71e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALDOB—liver cancer	1.02e-05	6.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CB—liver cancer	1.01e-05	6.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTM1—liver cancer	1e-05	6.56e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—liver cancer	9.94e-06	6.51e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CD—liver cancer	9.87e-06	6.46e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYCS—liver cancer	9.82e-06	6.43e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CRABP1—liver cancer	9.75e-06	6.39e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ALB—liver cancer	9.75e-06	6.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GOT1—liver cancer	9.63e-06	6.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GGT1—liver cancer	9.63e-06	6.31e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.57e-06	6.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP1A1—liver cancer	9.5e-06	6.22e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.43e-06	6.18e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—liver cancer	9.41e-06	6.16e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PSMD10—liver cancer	9.28e-06	6.08e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PSMA4—liver cancer	9.28e-06	6.08e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—H2AFX—liver cancer	9.25e-06	6.06e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RAF1—liver cancer	9.25e-06	6.06e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CG—liver cancer	9.12e-06	5.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CG—liver cancer	9.12e-06	5.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GOT2—liver cancer	9.03e-06	5.91e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CB—liver cancer	9.03e-06	5.91e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MTHFR—liver cancer	8.85e-06	5.8e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—liver cancer	8.81e-06	5.77e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—liver cancer	8.81e-06	5.77e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.78e-06	5.75e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	8.72e-06	5.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARA—liver cancer	8.69e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTP1—liver cancer	8.65e-06	5.67e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CB—liver cancer	8.6e-06	5.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HMOX1—liver cancer	8.53e-06	5.59e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HPGDS—liver cancer	8.52e-06	5.58e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2E1—liver cancer	8.49e-06	5.56e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.47e-06	5.55e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTHFR—liver cancer	8.39e-06	5.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—liver cancer	8.37e-06	5.48e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IL2—liver cancer	8.29e-06	5.43e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.22e-06	5.38e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CD—liver cancer	8.02e-06	5.25e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CD—liver cancer	8.02e-06	5.25e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	8.01e-06	5.24e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTM1—liver cancer	7.95e-06	5.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYCS—liver cancer	7.94e-06	5.2e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ALB—liver cancer	7.92e-06	5.19e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ALB—liver cancer	7.92e-06	5.19e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.8e-06	5.11e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GGT1—liver cancer	7.79e-06	5.1e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GOT1—liver cancer	7.79e-06	5.1e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.72e-06	5.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.62e-06	4.99e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PSMA4—liver cancer	7.6e-06	4.98e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PSMD10—liver cancer	7.6e-06	4.98e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP1A1—liver cancer	7.54e-06	4.94e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CG—liver cancer	7.44e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GOT2—liver cancer	7.39e-06	4.84e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—liver cancer	7.18e-06	4.7e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APC—liver cancer	7.05e-06	4.62e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—liver cancer	7.05e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MTHFR—liver cancer	7.03e-06	4.6e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTP1—liver cancer	7e-06	4.59e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CB—liver cancer	6.99e-06	4.58e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CB—liver cancer	6.99e-06	4.58e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2E1—liver cancer	6.95e-06	4.55e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HMOX1—liver cancer	6.91e-06	4.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARA—liver cancer	6.9e-06	4.52e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.73e-06	4.41e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—liver cancer	6.63e-06	4.34e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CD—liver cancer	6.54e-06	4.28e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYCS—liver cancer	6.5e-06	4.26e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TGFB1—liver cancer	6.47e-06	4.24e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALB—liver cancer	6.46e-06	4.23e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTM1—liver cancer	6.43e-06	4.21e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GGT1—liver cancer	6.38e-06	4.18e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GOT1—liver cancer	6.38e-06	4.18e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CD—liver cancer	6.2e-06	4.06e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.19e-06	4.06e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—liver cancer	6.17e-06	4.04e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SERPINE1—liver cancer	6.13e-06	4.01e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP1A1—liver cancer	6.1e-06	3.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—liver cancer	5.99e-06	3.92e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CG—liver cancer	5.91e-06	3.87e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTP1—liver cancer	5.73e-06	3.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CB—liver cancer	5.7e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—liver cancer	5.7e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTHFR—liver cancer	5.69e-06	3.72e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HMOX1—liver cancer	5.65e-06	3.7e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARA—liver cancer	5.58e-06	3.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RAF1—liver cancer	5.53e-06	3.62e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—liver cancer	5.5e-06	3.6e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTOR—liver cancer	5.4e-06	3.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CB—liver cancer	5.4e-06	3.54e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—liver cancer	5.32e-06	3.49e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTM1—liver cancer	5.27e-06	3.45e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—liver cancer	5.25e-06	3.43e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CD—liver cancer	5.19e-06	3.4e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALB—liver cancer	5.12e-06	3.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—liver cancer	5.09e-06	3.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1B—liver cancer	5.07e-06	3.32e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—liver cancer	5.04e-06	3.3e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.01e-06	3.28e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP1A1—liver cancer	4.99e-06	3.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CTNNB1—liver cancer	4.79e-06	3.14e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CG—liver cancer	4.78e-06	3.13e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—liver cancer	4.68e-06	3.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTHFR—liver cancer	4.65e-06	3.05e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—liver cancer	4.61e-06	3.02e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARA—liver cancer	4.57e-06	2.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CB—liver cancer	4.52e-06	2.96e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—liver cancer	4.5e-06	2.94e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—liver cancer	4.29e-06	2.81e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—liver cancer	4.26e-06	2.79e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—liver cancer	4.26e-06	2.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CD—liver cancer	4.2e-06	2.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—liver cancer	4.18e-06	2.73e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.1e-06	2.69e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CG—liver cancer	3.91e-06	2.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—liver cancer	3.88e-06	2.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TGFB1—liver cancer	3.87e-06	2.53e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—liver cancer	3.77e-06	2.47e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CB—liver cancer	3.66e-06	2.4e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—liver cancer	3.59e-06	2.35e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—liver cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—liver cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—liver cancer	3.47e-06	2.28e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CD—liver cancer	3.44e-06	2.25e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALB—liver cancer	3.39e-06	2.22e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—liver cancer	3.29e-06	2.16e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—liver cancer	3.05e-06	2e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CB—liver cancer	3e-06	1.96e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6—liver cancer	2.92e-06	1.91e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—liver cancer	2.84e-06	1.86e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—liver cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—liver cancer	2.69e-06	1.76e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—liver cancer	2.25e-06	1.48e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—liver cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—liver cancer	1.83e-06	1.2e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—liver cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—liver cancer	1.49e-06	9.77e-06	CbGpPWpGaD
